REPLIGEN CORPRGEN

Market cap

$9.2B

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	23	62	68	64	84	105	141	194	270	366	671	802	639	634
Revenue growth (%)	-
Cost of revenue	5	25	22	28	35	47	67	87	119	157	279	346	354	360
Research & development	9	10	7	6	6	7	9	16	19	20	34	44	43	43
Selling, general & administrative	9	13	13	17	25	31	52	66	96	120	184	216	218	263
Operating margin (%)
Operating income	-1,107,067	11	23	11	14	16	14	26	36	70	167	225	55	-35
Operating expenses	25	51	45	53	70	89	127	168	234	296	503	577	584	670
Income before tax	-1,596,881	11	23	11	13	12	7	21	26	59	154	219	64	-27
Pretax margin (%)	-6.8	18.1	33.8	17.5	16.1	11.2	5.1	11	9.7	16.2	22.9	27.3	10	-4.3
Provision for income taxes	15,744	-2,884,631	7	3	4	0	-21	5	5	-1	25	33	23	-2
Effective tax rate (%)
Net income	-1,612,625	14	16	8	9	12	28	17	21	60	128	186	42	-26
Net income margin (%)
Earnings per share	-0.05	0.46	0.51	0.25	0.28	0.35	0.74	0.38	0.44	1.14	2.33	3.35	0.75	-0.46
Diluted EPS	-0.05	0.45	0.5	0.25	0.28	0.34	0.72	0.37	0.44	1.11	2.24	3.24	0.74	-0.46